SCHEMBL28215586

SCHEMBL28215586

CC(C)(C)Oc1ccccc1C(=O)O.[Cu]

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.56
ALDH1A1 P00352 8/20 0.56
HSD17B10 Q99714 6/20 0.56
HPGD P15428 5/20 0.56
ESR1 P03372 1/20 0.56
ITGB3 P05106 1/20 0.56
ITGA2B P08514 1/20 0.56
HMGB1 P09429 1/20 0.56
TSHR P16473 1/20 0.56
GGT1 P19440 1/20 0.56
PTGS1 P23219 1/20 0.56
PTGS2 P35354 1/20 0.56
BLM P54132 1/20 0.56
NAPRT Q6XQN6 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
HTT P42858 2/20 0.53
LMNA P02545 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C9 P11712 1/20 0.50
USP2 O75604 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL282647 0.98 KDM4E (0.58) KDM4EALDH1A1HSD17B10HPGDESR1
SCHEMBL27344732 0.96 KDM4E (0.56) KDM4EALDH1A1HSD17B10HPGDESR1
SCHEMBL6559414 0.96 KDM4E (0.56) KDM4EALDH1A1HSD17B10HPGDESR1
SCHEMBL27997727 0.96 KDM4E (0.56) KDM4EALDH1A1HSD17B10HPGDESR1
SCHEMBL8645581 0.96 KDM4E (0.56) KDM4EALDH1A1HSD17B10HPGDESR1
Bicarbonate SCHEMBL238203 0.96 KDM4E (0.56) KDM4EALDH1A1HSD17B10HPGDESR1
Bicarbonate SCHEMBL29943603 0.96 KDM4E (0.56) KDM4EALDH1A1HSD17B10HPGDESR1
SCHEMBL3360162 0.96 KDM4E (0.56) KDM4EALDH1A1HSD17B10HPGDESR1
Bicarbonate SCHEMBL20694826 0.96 KDM4E (0.56) KDM4EALDH1A1HSD17B10HPGDESR1
Benzoic Acid SCHEMBL14763731 0.91 KDM4E (0.51) KDM4EALDH1A1HSD17B10HPGDESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105412125-B 3,5- di-tert-butyl salicylic acid copper are being prepared for treating the application in high metastatic breast cancer drug 江汉大学 2018-05-22 CN claimed